OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Respiratory and Critical Care Medicine is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
COVID-19 and Risk of Oxygen-Dependent Chronic Respiratory Failure: A National Cohort Study	1791
Targeting Autotaxin and Lysophosphatidic Acid in Pulmonary Fibrosis: Admilparant’s Positive Results Show Continued Promise	428
October 1 Highlight	398
Regulating the Regulators: Epigenetic Modulation of Regulatory T Cells in Pulmonary Hypertension	346
Reply to Jankowich: PRISm: What?s in a Name?	326
Determinants of Lung Fissure Completeness	263
Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease	250
Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions	230
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease	201
Genetically Identifying the “Thromboembolic” in Chronic Thromboembolic Pulmonary Hypertension	200
No One Left Behind: Access to Prevention and Treatment for All: Message on World Lung Day from M. Patricia Rivera, M.D. President of the American Thoracic Society	198
Outdoor Air Pollution and Your Health	196
Reply to Kasugai et al.: The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19	186
Enhancing Our Understanding of Breathing Mechanics in Nonintubated Patients with Acute Hypoxemic Respiratory Failure	177
Extending the Benefits of Pulmonary Rehabilitation to New Groups: Reply to Anidi et al.	151
Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults	144
Effect of P2Y12 Inhibitors, SGLT2 Inhibitors and P-Selectin Inhibitors on One-year Quality-of-Life Outcomes in Critically Ill Patients Hospitalized for COVID-19: A Pre-specified Secondary Analysis of	139
A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature	133
Nasal High Flow to Modulate Dyspnea in Orally Intubated Weanable Patients	133
Pulmonary FABP4 Is an Inverse Biomarker of Pneumonia in Critically Ill Children and Adults	128
Chronic Obstructive Pulmonary Disease Detection: Hurdles and Struggles	127
CPAP/BiPAP Administration and Cardiac Arrest Events in Hospitalized OSA/OHS Patients	124
Medical Necessity: When Patients and Providers Disagree	113
Association of the Q223R Leptin Receptor Polymorphism With Bacterial Pneumonia in the Michigan Genomics Initiative	111
Persistent Pneumatocele and Associated Effusion After Endobronchial Valve Placement	108

Artificial Intelligence- Based Deep Learning Model for Detecting Central and Upper Airway Obstruction on Flow-Volume Loops	106
Disseminated Mucormycosis Imitating Pulmonary Artery Embolism in a Pediatric Patient With Leukemia	106
Families' Preferred Information, Resources, and Supports During Decision-making for Prolonged Mechanical Ventilation and Throughout Chronic Critical Illness	105
Relative Risk of Death in Mechanically Ventilated COVID-19 and Respiratory Syncytial Virus Hospitalizations	101
Estimating the Greenhouse Gas Emissions of Outpatient Inhalers at Stanford Medicine	98
Does a Mediastinal Mass Mandate Biopsy? A Case of Esophageal Duplication Cyst ( Atypical Case of Posterior Mediastinal Mass)	98
Prediction of 5-Year Mortality in COPD Using Visual Measures of Structural Changes on Chest CT	97
TRPV4 Is a Key Mechanosensor in Macrophages That Drives Myofibroblast Differentiation Through Activation of TGF-β	94
Peripheral Chemoreceptors and Plant Gain as Key Elements of Eucapnic Ventilatory Drive in Idiopathic Hyperventilation Syndrome: A Prospective Case-Control Study Looking Under the Dogs' Tail	93
Differences in COVID-19 Vaccination Behaviors Among Adults With Versus Without Chronic Lower Respiratory Diseases: The C4R Study	93
Altered Peripheral γδT Cell Profiles With Increased IL-17A Secretion in Patients With Eosinophilic Granulomatosis With Polyangiitis	93
Diffuse Alveolar Hemorrhage in Lymphangioleiomyomatosis: A Case Series	93
Differential Gene Expression in Preterm Compared to Term-born Children Hospitalized With Rhinovirus Infection: Insights From RNA Sequencing	92
A Breathe of Uncertainty: Rare Cystic Lung Disease in Neurofibromatosis	92
Hemopneumothorax, Intraparenchymal Hemorrhage, and Hemoptysis as a Complication Following Bronchoscopic Lung-volume Reduction	91
Role of COPA Gene Mutation in Lung Epithelial Cells in COPA Syndrome Lung Disease	91
Leptospira(ls) to Pulmonary Hemorrhage	90
Death Crystals: Sign of Impending Doom	89
Lung to Gut: A Rare Occurrence of Pulmonary Manifestation of Crohn's Disease	88
Burden of Polypharmacy in the ED: A Breakdown of the Numbers	88
'Worsening Respiratory Failure in a Middle Aged Healthy Female'	86
Changes in Cardiac Effort in Pulmonary Hypertension-Interstitial Lung Disease: Insights From the Ascent Trial	86
The Great Masquerader: Cardiac Sarcoidosis Camouflaging as Asthma Exacerbation	84
Microplastics in Human Bronchoalveolar Lavage Fluid	80
Foreign Body Granulomatous Reaction Disguising as a Recurrent Lymphocytic Exudative Pleural Effusion	79
Incidental Finding of Left Intra-atrial Tumor in Transit Seen on Endobronchial Ultrasound Bronchoscopy	78
The Effect of Advanced Interventional Approaches on Patient Outcomes After Pulmonary Embolism	78
Lung Entrapment Syndrome From Multiloculated Empyema Necessitating Pleural Decortication	77
Clinical Manifestations and Management of Birt-Hogg-Dubé Syndrome	77
A Team-based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Interim Analysis of a Real-world Retrospective Study	77
Seeing the Light: Reflections on an Uncertain Lung Cancer Diagnosis	74
Insights Into Transcriptomic Variation Between Pericytes in Lung and Skin	73
A Tale of Two Effusions: Management of Pericardial Effusions in Two Patients With Precapillary Pulmonary Hypertension	73
Anomalous Pulmonary Venous Return Causing Group 1 Pulmonary Hypertension in a 79 Year Old Male	73
Unplugging the Pipe: Troubleshooting an Accidental One-Way Valve	73
Exploring Human Respiratory Organoids for Insights Into Influenza and Coronavirus Pathogenesis	72
Antifibrotic Therapy Combined With Pulmonary Vasodilator Therapy May Improve Survival in Patients With Idiopathic Pulmonary Fibrosis or Other Fibrotic ILD and Pulmonary Hypertension	72
Glucagon-Like Peptide-1 Receptor Agonists and Respiratory Diseases: A Systematic Review and Meta-Analysis	71
Descriptive Analysis of Patients With Amyotrophic Lateral Sclerosis (ALS) and Respiratory Support (RS) With Follow-up in the Pulmonology Department	70
Malignancy Masquerading as Amyopathic Dermatomyositis-associated Interstitial Lung Disease	70
Collateral Damage: Hemoptysis in a Child With Fontan Physiology	70
You GATA Follow Up Pulmonary Nodules	70
Understanding Nebulizer Utilization in Clinical Practice: A COPD Foundation Nebulizer Consortium Survey Study	69
Characteristics Associated With Regular Attendance and Quality of Asthma Annual Reviews in Adults With Asthma in England	69